Figure 4
From: Myosin binding protein H-like (MYBPHL): a promising biomarker to predict atrial damage
MYBPHL is not increased in plasma of patients without atrial damage. (A) Comparison of MYBPHL concentration in plasma of healthy volunteers (n = 11) with pre-OP values of patients with myocardial injury (n = 17). (B,C) Time course of MYBPHL in patients with AVR (B) (n = 5) or TAVI (C) (n = 5). The red line represents the mean concentration of MYBPHL in plasma of healthy controls. Values are presented as the mean ± SEM. n.s.: not significant.
